Clinical Trials Directory

Trials / Completed

CompletedNCT03816189

Role of Eosinophil in Fibrogenesis of Systemic Sclerosis

Role of Blood and Tissue Eosinophils in the Fibrogenesis of Systemic Sclerosis

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years – 66 Years
Healthy volunteers
Accepted

Summary

Eosinophils are involved in tissue remodeling and fibrosis in many inflammatory diseases. Systemic sclerosis (SSc) is an autoimmune disease with fibrotic skin and lung complications. The profibrosing properties and data from the SSc literature suggest a possible role of the eosinophils in the process of fibrogenesis of SSc.

Detailed description

it will assess the activation state of blood eosinophils in SSc patients compared to healthy controls (ECP production in vitro, surface activation markers, whole transcriptome array, ..). it will also study skin eosinophils and their recruitment (extracellular eosinophil granules, eotaxins production in skin, ..)

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood testPatients in each group will have a blood sample (9x7 mL) for eosinophils isolation, study of activation markers on whole blood and serum biomarkers testing
DIAGNOSTIC_TESTSkin biopsiesIn patients who will accept, skin biopsies will be performed in damaged and apparently normal skin, excluding fingers, hands, feet and face (biopsies are facultative)

Timeline

Start date
2018-10-03
Primary completion
2022-04-05
Completion
2022-04-05
First posted
2019-01-25
Last updated
2025-12-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03816189. Inclusion in this directory is not an endorsement.